asa guidelines for glp-1 agonists and Anesthesia: Considerations and Cautions CRNAs aGLP-1 receptor agonists & anesthesia:
Description
Patients should always work closely with a board-certified physician who can evaluate their health history, monitor for risks, and tailor dosing safely
Mol Endocrinol 1989;3:101421.ArticlePubMed 18
2014;307:R465R470
This article explains how semaglutide, tirzepatide, and retatrutide compare, why receptor activity matters, why clinical trial results should be interpreted carefully, and why physician-supervised treatment is essential for safe, sustainable results
